Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Intercellular communication is required for trap formation in the nematode-trapping fungus Duddingtonia flagrans.

Youssar L, Wernet V, Hensel N, Yu X, Hildebrand HG, Schreckenberger B, Kriegler M, Hetzer B, Frankino P, Dillin A, Fischer R.

PLoS Genet. 2019 Mar 27;15(3):e1008029. doi: 10.1371/journal.pgen.1008029. eCollection 2019 Mar.

2.

[Expectations of relatives concerning palliative home care].

Wiese CH, Morgenthal HC, Vossen-Wellmann A, Kriegler M, Klie S, Heidenblut B, Bartels UE, Graf BM, Hanekop GG.

Pflege Z. 2009 Feb;62(2):92-6. German.

PMID:
19263721
3.

Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans.

Hwu P, Yannelli J, Kriegler M, Anderson WF, Perez C, Chiang Y, Schwarz S, Cowherd R, Delgado C, Mulé J, et al.

J Immunol. 1993 May 1;150(9):4104-15.

PMID:
8473752
4.

Enhanced interaction of L-selectin with the high endothelial venule ligand via selectively oxidized sialic acids.

Norgard KE, Han H, Powell L, Kriegler M, Varki A, Varki NM.

Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1068-72.

5.
6.

Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection.

Choi K, Frommel TO, Stern RK, Perez CF, Kriegler M, Tsuruo T, Roninson IB.

Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7386-90.

7.

Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors.

Asher AL, Mulé JJ, Kasid A, Restifo NP, Salo JC, Reichert CM, Jaffe G, Fendly B, Kriegler M, Rosenberg SA.

J Immunol. 1991 May 1;146(9):3227-34.

8.

A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact.

Perez C, Albert I, DeFay K, Zachariades N, Gooding L, Kriegler M.

Cell. 1990 Oct 19;63(2):251-8.

PMID:
2208285
9.

Assembly of enhancers, promoters, and splice signals to control expression of transferred genes.

Kriegler M.

Methods Enzymol. 1990;185:512-27. No abstract available.

PMID:
2381328
10.

Laryngeal carcinoma in a Lynch syndrome II kindred.

Lynch HT, Kriegler M, Christiansen TA, Smyrk T, Lynch JF, Watson P.

Cancer. 1988 Sep 1;62(5):1007-13.

PMID:
3409161
11.

Transformation of human mammary epithelial cells by oncogenic retroviruses.

Clark R, Stampfer MR, Milley R, O'Rourke E, Walen KH, Kriegler M, Kopplin J, McCormick F.

Cancer Res. 1988 Aug 15;48(16):4689-94.

12.

Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II).

Lynch HT, Watson P, Lanspa SJ, Marcus J, Smyrk T, Fitzgibbons RJ Jr, Kriegler M, Lynch JF.

Dis Colon Rectum. 1988 Jun;31(6):439-44.

PMID:
3378468
13.
14.

Differential diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and Lynch syndrome II).

Lynch HT, Watson P, Kriegler M, Lynch JF, Lanspa SJ, Marcus J, Smyrk T, Fitzgibbons RJ Jr, Cristofaro G.

Dis Colon Rectum. 1988 May;31(5):372-7.

PMID:
3366037
15.

Flat adenomas in a colon cancer-prone kindred.

Lynch HT, Smyrk T, Lanspa SJ, Marcus JN, Kriegler M, Lynch JF, Appelman HD.

J Natl Cancer Inst. 1988 Apr 20;80(4):278-82.

PMID:
3351962
16.
17.

Clinical nuances of Lynch syndromes I and II.

Lynch HT, Watson P, Lanspa S, Marcus J, Smyrk T, Fitzgibbons R Jr, Cristofaro G, Kriegler M, Lynch J.

Prog Clin Biol Res. 1988;279:177-88. Review. No abstract available.

PMID:
3054919
18.

Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II).

Fitzgibbons RJ Jr, Lynch HT, Stanislav GV, Watson PA, Lanspa SJ, Marcus JN, Smyrk T, Kriegler MD, Lynch JF.

Ann Surg. 1987 Sep;206(3):289-95.

19.
21.
22.
23.
24.

Chemically facilitated microinjection of proteins into intact monolayers of tissue culture cells.

Kriegler MP, Livingston DM.

Somatic Cell Genet. 1977 Nov;3(6):603-10.

PMID:
601681

Supplemental Content

Loading ...
Support Center